Modification of the existing maximum residue levels for emamectin in various crops.
Emamectin
MRL
consumer risk assessment
insecticide
various commodities
Journal
EFSA journal. European Food Safety Authority
ISSN: 1831-4732
Titre abrégé: EFSA J
Pays: United States
ID NLM: 101642076
Informations de publication
Date de publication:
Aug 2021
Aug 2021
Historique:
entrez:
6
9
2021
pubmed:
7
9
2021
medline:
7
9
2021
Statut:
epublish
Résumé
In accordance with Article 6 of Regulation (EC) No 396/2005, the applicant Syngenta France S.A.S. submitted a request to the competent national authority in France to modify the existing maximum residue levels (MRLs) for emamectin. The data submitted in support of the request were found to be sufficient to derive MRL proposals for apricots, cherries, spinaches and similar leaves and herbal infusions from leaves and herbs, whereas a change of the existing MRL is not necessary for pome fruits. Adequate analytical methods for enforcement are available to control the residues of emamectin B1a on the commodities under consideration. Based on the risk assessment results, EFSA concluded that the short-term and long-term intake of residues resulting from the uses of emamectin benzoate according to the intended agricultural practices are unlikely to present a risk to consumer health. The consumer risk assessment shall be regarded as indicative since affected by uncertainty related to the data gaps identified in the MRL review.
Identifiants
pubmed: 34484450
doi: 10.2903/j.efsa.2021.6824
pii: EFS26824
pmc: PMC8404497
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e06824Informations de copyright
© 2021 European Food Safety Authority. EFSA Journal published by John Wiley and Sons Ltd on behalf of European Food Safety Authority.
Références
EFSA J. 2021 Aug 30;19(8):e06824
pubmed: 34484450
EFSA J. 2018 Apr 23;16(4):e05255
pubmed: 32625886
EFSA J. 2019 Aug 26;17(8):e05804
pubmed: 32626414
EFSA J. 2018 Jan 15;16(1):e05147
pubmed: 32625691
EFSA J. 2019 Jun 10;17(6):e05710
pubmed: 32626333
EFSA J. 2019 Aug 29;17(8):e05803
pubmed: 32626413